GlassScriptPhysician profile
Brandon James Slade
NPI 1154576239
$1,557.57
in general payments reported to CMS, 2019-2025
13 companies · $242 in 2025
The $242 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $332 · 2020: $25.77 · 2021: $34.66 · 2022: $67.18 · 2023: $646 · 2024: $209 · 2025: $242.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,097.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $590.38 | 2022-2024 | |
| Treace Medical Concepts, INC. | $345.73 | 2019-2025 | |
| Stryker Corporation | $329.53 | 2023-2025 | Citrefix, Actishield, Prostep Mica |
| Organogenesis INC. | $91.43 | 2020-2025 | Puraply, Cygnus Dual |
| Depuy Synthes Sales INC. | $43.60 | 2023 | Vivigen Mis Delivery System, Hammerlock, Motoband |
| Cornerstone Medical Associates, INC. | $40.59 | 2023 | |
| Integra Lifesciences Corporation | $18.95 | 2022 | |
| Bioventus LLC | $18.04 | 2023 | Exogen Ultrasound Bone Healing System |
| Averitas Pharma INC. | $17.47 | 2025 | Qutenza |
| Pacira Pharmaceuticals Incorporated | $17.00 | 2021 | |
| Paragon 28, INC. | $16.68 | 2025 | Precision Mis Bunion |
| Medtronic, INC. | $14.44 | 2023 | Intellis Adaptivestim |
| Triad Life Sciences INC. | $13.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Slade listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.